Rici Healthcare reports revenue dip, but gross profit margin improves

Rici Healthcare Holdings Limited announced its interim results for the six months ended June 30, 2025, with total revenue of 1,144.8 million yuan, a 7.0% decrease from the corresponding period of 2024. This decline was primarily attributed to competitive pressures affecting the general hospital business, which saw a revenue drop of 28.7% to 219.7 million yuan (excluding inter-segment revenue). In contrast, the medical examination business experienced a slight increase of 0.2% to 925.1 million yuan, driven by growth in its "XMEDIC" brand.

Despite the revenue decrease, gross profit rose to 407.6 million yuan from 396.3 million yuan, with the gross profit margin improving from 32.2% to 35.6% due to efficiency and cost reduction measures. However, profit attributable to owners of the company decreased to 55.9 million yuan from 84.9 million yuan. Adjusted EBITDA also fell by 5.4% to 386.6 million yuan, largely due to the revenue decline in the general hospital sector.

The company's current liabilities exceeded current assets by 266.2 million yuan as of June 30, 2025. The board has resolved not to declare an interim dividend for the period.